Imbruvica

Imbruvica ATC Classification

ibrutinib

Manufacturer:

Catalent CTS

Distributor:

Johnson & Johnson
Full Prescribing Info
ATC Classification
L01EL01 - ibrutinib ; Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in